Table 3 Change in hypertensive and diuretic medications during the 12-month study period
Medication | Control | LI | P value | ||
|---|---|---|---|---|---|
Commenced | Ceased | Commenced | Ceased | ||
ACE inhibitor, n(%) | + 1(1.5) | −5(7.4) | + 1(1.4) | −7(9.5) | 0.83 |
ATRB, n(%) | + 4(5.9) | − 2(2.9) | +6(8.1) | − 6(8.1) | 0.30 |
Thiazide, n(%) | + 1(1.5) | −2(2.9) | + 1(1.4) | −3(4.1) | 0.90 |
Spironolactone, n(%) | 0 | −2(2.9) | 0 | 0 |  |
Loop diuretics, n(%) | +6(8.8) | −3(4.4) | + 4(5.4) | −3(4.1) | 0.76 |